NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

In a healthcare industry that has become inundated with physicians who overprescribe pain medication and are all too eager to ...

A study shows pain coping skills training (PCST) significantly alleviates chronic pain in dialysis patients, enhancing their quality of life.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...